{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:39:35Z","timestamp":1784907575416,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["R01CA20740"],"award-info":[{"award-number":["R01CA20740"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5TL1TR002244"],"award-info":[{"award-number":["5TL1TR002244"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5U01C10003"],"award-info":[{"award-number":["5U01C10003"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA20740"],"award-info":[{"award-number":["R01CA20740"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5TL1TR002244"],"award-info":[{"award-number":["5TL1TR002244"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K07CA225404"],"award-info":[{"award-number":["K07CA225404"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.amepre.2021.08.017","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T09:16:27Z","timestamp":1635498987000},"page":"395-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7064-4424","authenticated-orcid":false,"given":"Jaimie Z.","family":"Shing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie R.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-2757","authenticated-orcid":false,"given":"Rachel S.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Beeghly-Fadiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci L.","family":"Sudenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Slaughter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-4295","authenticated-orcid":false,"given":"Manideepthi","family":"Pemmaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Mitchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-9087","authenticated-orcid":false,"given":"Pamela C.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3.5","key":"10.1016\/j.amepre.2021.08.017_bib0001","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2018.7182","article-title":"HSR19-102: direct and indirect economic burden of cervical cancer (CxCa) in the United States in 2015: a mixed-methods analysis","volume":"17","author":"Nwankwo","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.amepre.2021.08.017_bib0002","article-title":"The economic burden of human papillomavirus-related precancers and cancers in Sweden [published correction appears in PLoS One. 2018;13(7):e0200554]","volume":"12","author":"\u00d6stensson","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.amepre.2021.08.017_bib0003","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/jwh.2019.7858","article-title":"Economic and humanistic burden of cervical cancer in the United States: results from a nationally representative survey","volume":"29","author":"Shah","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"issue":"11","key":"10.1016\/j.amepre.2021.08.017_bib0004","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.amepre.2021.08.017_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"de Sanjos\u00e9","year":"2018","journal-title":"JNCI Cancer Spectr"},{"issue":"15","key":"10.1016\/j.amepre.2021.08.017_bib0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.15585\/mmwr.mm6815a1","article-title":"Estimated number of cases of high-grade cervical lesions diagnosed among women - United States, 2008 and 2016","volume":"68","author":"McClung","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"10.1016\/j.amepre.2021.08.017_bib0007","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.amepre.2021.08.017_bib0008","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.15585\/mmwr.mm6933a1","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years - United States, 2019","volume":"69","author":"Elam-Evans","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"10.1016\/j.amepre.2021.08.017_bib0009","doi-asserted-by":"crossref","first-page":"718","DOI":"10.15585\/mmwr.mm6833a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2018","volume":"68","author":"Walker","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.amepre.2021.08.017_bib0010","first-page":"147","article-title":"American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.amepre.2021.08.017_bib0011","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors [published correction appears in J Low Genit Tract Dis. 2020;24(4):427]","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"21","key":"10.1016\/j.amepre.2021.08.017_bib0012","first-page":"6027","article-title":"A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ","volume":"60","author":"Ylitalo","year":"2000","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.amepre.2021.08.017_bib0013","first-page":"535","article-title":"Screening for cervical cancer: should we test for infection with high-risk HPV?","volume":"163","author":"Meijer","year":"2000","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.amepre.2021.08.017_bib0014","first-page":"135","article-title":"Human papillomavirus: confronting the epidemic-a urologist\u2019s perspective","volume":"7","author":"Watson","year":"2005","journal-title":"Rev Urol"},{"issue":"2S","key":"10.1016\/j.amepre.2021.08.017_bib0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.acap.2017.09.014","article-title":"Ten years of human papillomavirus vaccination in the United States","volume":"18","author":"Markowitz","year":"2018","journal-title":"Acad Pediatr"},{"issue":"1","key":"10.1016\/j.amepre.2021.08.017_bib0016","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amepre.2018.03.015","article-title":"Trends in high-grade cervical cancer precursors in the human papillomavirus vaccine era","volume":"55","author":"Oakley","year":"2018","journal-title":"Am J Prev Med"},{"issue":"16","key":"10.1016\/j.amepre.2021.08.017_bib0017","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.29266","article-title":"Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States","volume":"121","author":"Hariri","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.amepre.2021.08.017_bib0018","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cid\/ciy707","article-title":"Trends in high-grade cervical lesions and cervical cancer screening in 5 states, 2008-2015","volume":"68","author":"Gargano","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amepre.2021.08.017_bib0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era","volume":"3","author":"Benard","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.amepre.2021.08.017_bib0020","unstructured":"Human papillomavirus vaccine impact monitoring project (HPV-IMPACT): overview. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/ncird\/surveillance\/hpvimpact\/overview.html. Updated August 13, 2020. Accessed February 9, 2019."},{"issue":"12","key":"10.1016\/j.amepre.2021.08.017_bib0021","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2105\/AJPH.2016.303472","article-title":"Ecological association of human papillomavirus vaccination with cervical dysplasia prevalence in the United States, 2007-2014","volume":"106","author":"Flagg","year":"2016","journal-title":"Am J Public Health"},{"issue":"10","key":"10.1016\/j.amepre.2021.08.017_bib0022","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1089\/wound.2013.0478","article-title":"ICD-9-CM to ICD-10-CM codes: what? Why? How?","volume":"2","author":"Cartwright","year":"2013","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"1","key":"10.1016\/j.amepre.2021.08.017_bib0023","doi-asserted-by":"crossref","first-page":"pkaa112","DOI":"10.1093\/jncics\/pkaa112","article-title":"Improving cervical precancer surveillance: validity of claims-based prediction models in ICD-9 and ICD-10 eras","volume":"5","author":"Shing","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.amepre.2021.08.017_bib0024","unstructured":"Average annual percent change (AAPC) and confidence interval. NIH, National Cancer Institute, Division of Cancer Control & Population Sciences. https:\/\/surveillance.cancer.gov\/help\/joinpoint\/setting-parameters\/method-and-parameters-tab\/average-annual-percent-change-aapc. Updated February, 6, 2018. Accessed December 4, 2017."},{"issue":"RR-2","key":"10.1016\/j.amepre.2021.08.017_bib0025","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.amepre.2021.08.017_bib0026","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/AOG.0b013e3181a6d022","article-title":"ACOG committee opinion no. 431: routine pelvic examination and cervical cytology screening","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amepre.2021.08.017_bib0027","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"de Sanjos\u00e9","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"9590","key":"10.1016\/j.amepre.2021.08.017_bib0028","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"354","key":"10.1016\/j.amepre.2021.08.017_bib0029","first-page":"1","article-title":"Human papillomavirus vaccination among adults aged 18\u201226, 2013-2018","author":"Boersma","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"8","key":"10.1016\/j.amepre.2021.08.017_bib0030","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1158\/1055-9965.EPI-13-0272","article-title":"Declining rates of high-grade cervical lesions in young women in Connecticut, 2008-2011","volume":"22","author":"Niccolai","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"suppl 2","key":"10.1016\/j.amepre.2021.08.017_bib0031","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/00333549111260S214","article-title":"Vaccination coverage among U.S. adolescents aged 13\u201317 years eligible for the Vaccines for Children Program, 2009","volume":"126","author":"Lindley","year":"2011","journal-title":"Public Health Rep"},{"issue":"6","key":"10.1016\/j.amepre.2021.08.017_bib0032","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3833","article-title":"Trends in frequency of sexual activity and number of sexual partners among adults aged 18 to 44 years in the U.S., 2000-2018","volume":"3","author":"Ueda","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2021.08.017_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105927","article-title":"Risk prediction of cervical abnormalities: the value of sociodemographic and lifestyle factors in addition to HPV status","volume":"130","author":"van der Waal","year":"2020","journal-title":"Prev Med"},{"issue":"10","key":"10.1016\/j.amepre.2021.08.017_bib0034","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/OLQ.0000000000001053","article-title":"Determinants of acquisition and clearance of human papillomavirus infection in previously unexposed young women","volume":"46","author":"El-Zein","year":"2019","journal-title":"Sex Transm Dis"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379721004979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379721004979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:42:39Z","timestamp":1778506959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379721004979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0749379721004979"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2021.08.017","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2021.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Journal of Preventive Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}